{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T17:04:58Z","timestamp":1786554298580,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/ctg.2015.36","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T10:42:17Z","timestamp":1444300937000},"page":"e114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease"],"prefix":"10.14309","volume":"6","author":[{"given":"Jessica L","family":"Mueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin R","family":"Feeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Misdraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie J","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Alatrakchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay Y","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Gelrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond T","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210317","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0028-1091978","article-title":"The epidemiology of nonalcoholic fatty liver disease: a global perspective.","volume":"28","author":"Lazo","year":"2008","journal-title":"Semin Liver Dis"},{"key":"R2-2-20210317","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"R3-2-20210317","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes.","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"R4-2-20210317","first-page":"820","article-title":"Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies.","volume":"40","author":"Fassio","year":"2004","journal-title":"Hepatology"},{"key":"R5-2-20210317","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"St, Sauver J et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study.","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"R6-2-20210317","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/00007890-199305000-00029","article-title":"Liver biopsy. Its safety and complications as seen at a liver transplant center.","volume":"55","author":"Van Thiel","year":"1993","journal-title":"Transplantation"},{"key":"R7-2-20210317","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"R8-2-20210317","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5009\/gnl.2012.6.2.149","article-title":"NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications.","volume":"6","author":"Farrell","year":"2012","journal-title":"Gut Liver"},{"key":"R9-2-20210317","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1007\/s11695-007-9243-7","article-title":"Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis.","volume":"17","author":"Ruiz","year":"2007","journal-title":"Obes Surg"},{"key":"R10-2-20210317","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"R11-2-20210317","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1182\/blood.V99.1.378","article-title":"Identification of the hemoglobin scavenger receptorCD163 as a natural soluble protein in plasma.","volume":"99","author":"Moller","year":"2002","journal-title":"Blood"},{"key":"R12-2-20210317","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1189\/jlb.72.4.711","article-title":"Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163.","volume":"72","author":"Hintz","year":"2002","journal-title":"J Leukoc Biol"},{"key":"R13-2-20210317","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jlb.55.2.248","article-title":"Quantitative discrimination of hepatic reticuloendothelial clearance and phagocytic killing.","volume":"55","author":"Klein","year":"1994","journal-title":"J Leukoc Biol"},{"key":"R14-2-20210317","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10096-013-1936-3","article-title":"Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.","volume":"33","author":"Andersen","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R15-2-20210317","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.27129","article-title":"Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.","volume":"60","author":"Kazankov","year":"2014","journal-title":"Hepatology"},{"key":"R16-2-20210317","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/gutjnl-2012-304135","article-title":"Hepatic macrophage activation predicts clinical decompensation in chronic liver disease.","volume":"62","author":"Rode","year":"2013","journal-title":"Gut"},{"key":"R17-2-20210317","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/gut.2010.234542","article-title":"Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS.","volume":"60","author":"Holland-Fischer","year":"2011","journal-title":"Gut"},{"key":"R18-2-20210317","first-page":"49","article-title":"Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease.","volume":"30","author":"De Vito","year":"2012","journal-title":"Int J Mol Med"},{"key":"R19-2-20210317","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2012.05.012","article-title":"Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.","volume":"16","author":"Imajo","year":"2012","journal-title":"Cell Metab"},{"key":"R20-2-20210317","doi-asserted-by":"crossref","first-page":"36430","DOI":"10.1074\/jbc.M003192200","article-title":"Hepatocytes contribute to soluble CD14 production, and CD14 expression is differentially regulated in hepatocytes and monocytes.","volume":"275","author":"Pan","year":"2000","journal-title":"J Biol Chem"},{"key":"R21-2-20210317","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/jhep.2003.50038","article-title":"Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.","volume":"37","author":"Albillos","year":"2003","journal-title":"Hepatology"},{"key":"R22-2-20210317","doi-asserted-by":"crossref","first-page":"e89341","DOI":"10.1371\/journal.pone.0089341","article-title":"Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis.","volume":"9","author":"Quon","year":"2014","journal-title":"PLoS One"},{"key":"R23-2-20210317","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease.","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"R24-2-20210317","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hep.24376","article-title":"Endpoints and clinical trial design for nonalcoholic steatohepatitis.","volume":"54","author":"Sanyal","year":"2011","journal-title":"Hepatology"},{"key":"R25-2-20210317","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"key":"R26-2-20210317","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1214\/09-SS054","article-title":"A survey of cross-validation procedures for model selection.","volume":"4","author":"Arlot","year":"2010","journal-title":"Statistics surveys"},{"key":"R27-2-20210317","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/jgh.12943","article-title":"The macrophage activation marker sCD163 is independently associated with NAFLD severity in morbid obesity and reduced by bariatric surgery.","volume":"30","author":"Kazankov","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"R28-2-20210317","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/ATVBAHA.113.303153","article-title":"Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection.","volume":"34","author":"Shaked","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R29-2-20210317","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1053\/j.gastro.2011.06.063","article-title":"Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.","volume":"141","author":"Sandler","year":"2011","journal-title":"Gastroenterology"},{"key":"R30-2-20210317","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/hep.27303","article-title":"Landay AL et al. sCD163 is associated with non-invasive measures of liver fibrosis in HCV- and HCVHIV-infected women.","volume":"61","author":"Kuniholm","year":"2014","journal-title":"Hepatology"},{"key":"R31-2-20210317","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00535-004-1493-8","article-title":"Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure.","volume":"40","author":"Hiraoka","year":"2005","journal-title":"J Gastroenterol"},{"key":"R32-2-20210317","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2036.2012.05134.x","article-title":"Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.","volume":"36","author":"Gronbaek","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R33-2-20210317","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/infdis\/jir520","article-title":"Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.","volume":"204","author":"Burdo","year":"2011","journal-title":"J Infect Dis"},{"key":"R35-2-20210317","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.2011.04284.x","article-title":"Relationship between monocytemacrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects.","volume":"77","author":"Zanni","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R36-2-20210317","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/oby.20376","article-title":"The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss.","volume":"21","author":"Fjeldborg","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"R37-2-20210317","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.21223","article-title":"In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.","volume":"44","author":"Wieckowska","year":"2006","journal-title":"Hepatology"},{"key":"R38-2-20210317","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2013.07.042","article-title":"Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease.","volume":"60","author":"Cusi","year":"2014","journal-title":"J Hepatol"},{"key":"R39-2-20210317","doi-asserted-by":"crossref","first-page":"e90541","DOI":"10.1371\/journal.pone.0090541","article-title":"Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection.","volume":"9","author":"Beltran","year":"2014","journal-title":"PLoS One"}],"container-title":["Clinical and Translational Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ctg201536.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ctg201536","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/01720094-201510000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ctg201536.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:20:45Z","timestamp":1786544445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01720094-201510000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1038\/ctg.2015.36","relation":{},"ISSN":["2155-384X"],"issn-type":[{"value":"2155-384X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}